Medical Giants Join Forces, Ushering in a Transformative Era in Cardiac Imaging

Gentuity: An Emerging Innovator

Gentuity, focusing on intravascular imaging innovation, has been committed to developing groundbreaking imaging technology since its establishment.

Gentuity's core product, the high-frequency Optical Coherence Tomography (OCT) imaging system, is undoubtedly the best demonstration of its technical strength. This mobile console, equipped with advanced machine learning technology, not only enables rapid setup, significantly reducing pre-surgical preparation time, but also provides highly detailed imaging capabilities, allowing doctors to clearly observe minute structures and pathological changes inside blood vessels. Its high resolution and precise detail presentation make it stand out among similar products.

The Vis - Rx prime micro-imaging catheter is Gentuity's masterpiece, labeled as the world's smallest imaging catheter with a diameter of only 1.8F. It plays a significant role both before and after percutaneous coronary intervention (PCI) surgery by providing comprehensive vascular imaging. Its unique design allows it to easily reach areas that are difficult for traditional catheters to access, offering doctors more comprehensive and accurate vascular information to help them develop more precise treatment plans.

GE Healthcare: A Giant with Deep Roots in the Industry

GE Healthcare, always at the forefront of medical technology innovation, continuously drives the development and progress of the industry, with its influence extending globally. Its business scope covers several key areas such as medical imaging, patient care solutions, and pharmaceutical diagnostics, providing comprehensive and integrated medical services to patients and healthcare institutions worldwide. In terms of cardiovascular and interventional solutions, GE Healthcare boasts numerous advanced technologies and extensive clinical experience. The various medical devices it has developed, such as high-end ultrasound diagnostic equipment and advanced cardiac catheterization devices, have become benchmark products within the industry.

In Improving the Availability of Complementary Imaging Solutions in Interventional Cardiology, the Collaboration Between the Two Parties Has Many Concrete Manifestations. In the past, some advanced imaging equipment was out of reach for many small and medium-sized medical institutions due to high costs and complex maintenance. Through this collaboration, the two parties will jointly optimize the product supply chain, reduce costs, and enable more medical institutions to afford these advanced imaging devices. At the same time, they will strengthen the construction of after-sales service networks to ensure that equipment can be repaired and maintained promptly and effectively when malfunctions occur, thereby increasing equipment uptime and further enhancing availability.

In terms of promoting adoption, the two parties will carry out a series of professional training activities. Personalized training courses will be developed for medical personnel at different levels, covering everything from basic device operation to advanced applications, from image interpretation skills to clinical case analysis, comprehensively enhancing medical personnel's mastery of new imaging technologies. Through these trainings, healthcare professionals will deeply recognize the significant advantages of new imaging technologies in clinical diagnosis and treatment, thereby motivating their enthusiasm to proactively adopt these new technologies.

In terms of enhancing functionality, GE HealthCare's deep technical expertise in medical imaging processing and analysis, combined with Gentuity's advanced imaging hardware, is expected to achieve more precise detection and analysis of vascular lesions. For instance, by employing deep learning on a large volume of clinical imaging data, smarter image recognition algorithms can be developed to automatically identify tiny plaques, narrowed sections, and other lesion characteristics within blood vessels, providing detailed quantitative analysis reports that offer doctors more accurate diagnostic support.

Technical integration is one of the core highlights of this collaboration. GE HealthCare has extensive experience in system integration and software algorithms for medical devices, while Gentuity's high-frequency OCT imaging systems and Vis-Rx prime micro-imaging catheters offer unique hardware advantages. By deeply integrating these complementary technologies, the two parties can achieve a 1+1>2 effect. For example, applying GE HealthCare's advanced image fusion algorithms to Gentuity's imaging catheters allows doctors to simultaneously obtain more vascular information during surgery, such as vessel morphology, structure, and hemodynamic parameters, enabling a more comprehensive and accurate assessment of the condition and the formulation of more scientific treatment plans. This technical integration not only enhances the performance of existing products but may also give rise to new product forms and application scenarios, bringing entirely new development opportunities to the field of interventional cardiology imaging.

The cooperation between Gentuity and GE HealthCare will undoubtedly become a significant step forward in the field of cardiovascular intervention."Precision + Intelligence"A powerful booster in the new era.

In terms of precision, the imaging technology developed through the collaboration between the two parties can provide doctors with more detailed and accurate intravascular information. In the past, during cardiovascular interventional surgeries, doctors might face increased surgical risks and suboptimal treatment outcomes due to insufficiently precise understanding of vascular lesions. Now, with Gentuity’s high-frequency OCT imaging system and Vis-Rx prime micro-imaging catheter, combined with GE Healthcare’s advanced image processing technology, doctors can clearly observe tiny vascular lesions, such as early atherosclerotic plaques and subtle damage to the vessel walls. This enables precise diagnosis and assessment of the condition. It is akin to equipping doctors with a "precise scalpel," allowing them to perform operations more accurately, minimize damage to healthy tissues, and improve the success rate and safety of surgeries.

From an intelligence perspective, the integration of artificial intelligence technology in Gentuity products with GE HealthCare's intelligent algorithms will significantly enhance the level of surgical intelligence. During surgery, the imaging system can analyze vascular conditions in real time and provide doctors with immediate surgical recommendations and risk alerts based on preset algorithms and extensive clinical data. For instance, when the degree of vascular stenosis reaches a certain threshold, the system will automatically prompt the doctor to take corresponding treatment measures; if it detects that the surgical procedure might affect surrounding critical tissues, the system will promptly issue an alert. This intelligent assistance not only reduces the workload of doctors and minimizes the risk of human error but also makes the surgical process smoother and more efficient, offering patients a better treatment experience.

This Issue's Planning: Shen Li

Editorial Responsibility: Chen Baolin

Author of this article: Yun Ye Xuan

Post-production: Zhang Lirong